Senti Biosciences, Inc. (SNTI) Earnings History
Net Loss7 years of earnings data (2019–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Senti Biosciences, Inc. (SNTI) Earnings Overview
As of June 24, 2026, Senti Biosciences, Inc. (SNTI) reported trailing twelve-month net income of -$52M, reflecting +76.2% year-over-year growth. The company earned $-1.66 per diluted share over the past four quarters, with a net profit margin of -279263.6%.
Looking at the long-term picture, SNTI's historical earnings data spans multiple years. The company achieved its highest annual net income of -$20M in fiscal 2020.
Senti Biosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including FATE (-$130M net income, -2051.1% margin), CRSP (-$569M net income, -16569.8% margin), NTLA (-$395M net income, -609.9% margin), SNTI has room to improve margins relative to the peer group. Compare SNTI vs FATE →
SNTI Earnings vs Peers
Earnings metrics vs comparable public companies
SNTI Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$61M | -16.4% | -$64M | $-2.73 | -279263.6% | -289668.2% |
| 2024 | -$53M | +25.7% | -$61M | $-11.49 | - | - |
| 2023 | -$71M | -22.1% | -$93M | $-20.94 | -3592.4% | -4687.9% |
| 2022 | -$58M | -5.2% | -$62M | $-13.25 | -1771.5% | -1889.3% |
| 2021 | -$55M | -178.5% | -$40M | $-12.67 | -2414.6% | -1765.4% |
| 2020 | -$20M | +6.1% | -$25M | $-4.55 | -5041.1% | -6267.5% |
| 2019 | -$21M | - | -$22M | $-15.57 | -24890.6% | -25625.9% |
Download Data
Export SNTI earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SNTI — Frequently Asked Questions
Quick answers to the most common questions about buying SNTI stock.
What is SNTI earnings per share (EPS)?
SNTI trailing twelve-month (TTM) diluted EPS is $-1.66, reflecting +76.2% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is Senti Biosciences, Inc.'s net income?
Senti Biosciences, Inc. (SNTI) trailing twelve-month net income is $-52M as of 2025. Earnings grew +76.2% year-over-year.
Is SNTI profitable?
SNTI is not currently profitable on a TTM basis, reporting a net loss of $-52M. Net margin is -279263.6%. Investors should monitor for a return to profitability.
What is SNTI's earnings growth rate?
SNTI compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are SNTI's profit margins?
Senti Biosciences, Inc. net profit margin is -279263.6%, operating margin is -289668.2%, and gross margin is -16431.8%. Below-average margins reflect competitive or cost pressures. Return on Equity is -393.4%.
Is SNTI growing earnings?
Yes, SNTI earnings are accelerating — EPS growth of +76.2% exceeds the 5-year CAGR of N/A. TTM net income reached $-52M. Earnings momentum is strengthening.
What was SNTI's best earnings year?
Senti Biosciences, Inc.'s highest annual net income on record is $-20M, achieved in fiscal year 2020. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were SNTI's earnings last quarter?
SNTI's most recent reported quarter was Q1 2026. Net income was $-4M with diluted EPS of $-0.14. For a full breakdown of all quarters, see the quarterly earnings table on this page.